U.S. Hereditary Angioedema Therapeutics Market
United States Hereditary Angioedema Therapeutics Market Soars to New Heights, Projections to 2029
July 16, 2024 11:22 ET | Research and Markets
Dublin, July 16, 2024 (GLOBE NEWSWIRE) -- The "United States Hereditary Angioedema Therapeutics Market, By Region, Competition, Forecast and & Opportunities, 2019-2029F" report has been added to...
Contrive Datum Insights_Logo.jpg
Global Hereditary Angioedema Market Is Estimated To Be Valued At US$ 2,431.89 Million In 2022 And Is Expected To Exhibit A CAGR Of 9.1% During The Forecast Period (2022-2030) | Data By Contrive Datum Insights Pvt Ltd.
April 25, 2023 12:56 ET | Contrive Datum Insights Pvt Ltd
Farmington, April 25, 2023 (GLOBE NEWSWIRE) -- The Hereditary Angioedema Market size was valued at USD 2431.89 Million in 2022 and is projected to reach USD 4881.37 Million by 2030, growing at a...
Global Hereditary Angioedema Market
Global Hereditary Angioedema Market Report to 2030 - by Drug Class, Route of Administration, Distribution Channel and Region
August 31, 2022 07:03 ET | Research and Markets
Dublin, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The "Hereditary Angioedema Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering....